Medicines Co (MDCO.O)
21 Oct 2016
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|67||2015||Non-Executive Chairman of the Board|
|50||2016||President, Chief Operating Officer|
|58||2015||Chief Executive Officer, Director|
|57||2016||Chief Financial Officer, Principal Accounting Officer|
|51||2016||Executive Vice President, chief corporate development officer|
- BRIEF-Medicines Co announces positive top-line results from day 90 interim analysis in ongoing Orion-1 Phase 2 study of PCSK9si
- BRIEF-The Medicines Company says provides update on PCSK9si study
- BRIEF-Medicines Co receives funding of up to $132 mln from BARDA
- U.S. to invest in Medicines Co, Roche antibiotics development
- BRIEF-Medicines company provides update on Dyslipidemia programs